Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

42.04

+0.16 (0.38%)

At close: May 28, 2025, 4:00 PM

42.05

+0.01 (0.02%)

After-hours: May 28, 2025, 4:10 PM EDT

Tarsus Pharmaceuticals Employees

Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.

Employees

323

Change (1Y)

79

Growth (1Y)

32.38%

Revenue / Employee

$723,449

Profits / Employee

-$324,901

Market Cap

1.77B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	323	79	32.38%
Dec 31, 2023	244	157	180.46%
Dec 31, 2022	87	41	89.13%
Dec 31, 2021	46	26	130.00%
Dec 31, 2020	20	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

TARS News

16 days ago - Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off - Seeking Alpha
20 days ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
23 days ago - Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - PRNewsWire
26 days ago - Tarsus Pharmaceuticals, Inc. (TARS) Q1 2025 Earnings Call Transcript - Seeking Alpha
27 days ago - Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements - GlobeNewsWire
4 weeks ago - Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - GlobeNewsWire
5 weeks ago - Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting - GlobeNewsWire
2 months ago - Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewsWire